OR WAIT null SECS
© 2021 MJH Life Sciences and Infection Control Today. All rights reserved.
© 2021 MJH Life Sciences™ and Infection Control Today. All rights reserved.
April 13, 2021
The CDC and FDA are expected to announce an immediate pause for administering the one-shot adenovirus Ad26.COV2.S while advising states distributing the product to consider doing the same.
March 29, 2021
The study states that it is “extremely unlikely” the pandemic virus occurred through a laboratory leak in Wuhan, China.
March 08, 2021
The CDC guidance states that persons past 2 weeks of their final COVID-19 vaccine dose face little risk from unmasked, non-distancing indoor visiting of unvaccinated, low-risk members from a single household.
February 24, 2021
Janssen Ad26.COV2.S is an intramuscular injection vaccine consisting of a replication-incompetent recombinant adenovirus type 26 (Ad26) vector which expresses the SARS-CoV-2 spike (S) protein.